OQS.F Nanosonics Limited

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
1.68 EUR
Close of Nov 12, 2026
1.58 2.48
Market cap
EUR 503M
P/E
56.0x
P/B
3.69x
ROE
8.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is OQS.F undervalued?

Graham number

The Graham number of Nanosonics Limited cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanosonics Limited fundamental analysis

No fundamental analysis for Nanosonics Limited yet.

Nanosonics Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanosonics Limited

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infec…

Full company profile